This is a non-core endpoint: only basic statistics are computed.
Abnormal findings on diagnostic imaging and in function studies, without diagnosis
R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_FUNCTION_STUDI_WO_DIAGNOSIS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
23001
Check minimum number of events None
23001
Include endpoints
23001
Remove individuals based on genotype QC
22257
R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_FUNCTION_STUDI_WO_DIAGNOSIS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R
Name in latin
Reperta abnormia ex imagine diagnostica et studio functionum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Abnormal findings on diagnostic imaging and in function studies, without diagnosis
based on the number of shared cases.
Broader endpoints:
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 22257 | 10820 | 11437 |
| Unadjusted prevalence (%) | 5.90 | 5.13 | 6.88 |
| Mean age at first event (years) | 62.59 | 59.66 | 65.36 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_FUNCTION_STUDI_WO_DIAGNOSIS – Abnormal findings on diagnostic imaging and in function studies, without diagnosis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Abnormal findings on diagnostic imaging and in function studies, without diagnosis
↥Endpoint not on priority list, no data to show.